Discovery of Enzyme Provides New Drug Target for Parkinson’s Disease

Asparagine endopeptidase (AEP), an enzyme already identified as a contributor to the tangling of tau proteins and increasing neurotoxicity in Alzheimer’s cases, is now also believed to activate cleaving of alpha-synuclein in humans which leads to the formation of Lewy bodies, also increasing neurotoxicity in patients with Parkinson disease. Researchers plan to explore the possibilities … Continue reading Discovery of Enzyme Provides New Drug Target for Parkinson’s Disease